Myostatin Levels in <scp>SMA</scp> Following Disease‐Modifying Treatments: A Multi‐Center Study

This study demonstrates lower myostatin levels in SMA patients compared to controls. The association between myostatin levels, functional status, and SMA type suggests its possible role as a disease severity biomarker. The utility of myostatin as a biomarker for DMT response remains controversial; while we observed no significant increase in myostatin levels following treatment, we also did not observe the progressive reduction previously reported in untreated patients.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2025-05-14
DOI
https://doi.org/10.1002/acn3.70070
Citations
1
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myostatin Levels in SMA Following Disease‐Modifying Treatments: A Multi‐Center Study

Adele D’Amico, Antonio Novelli, Giorgia Coratti, Fiorella Piemonte et al.
1 citations
Annals of Clinical and Translational Neurology
Muscle Physiology and Disorders
0.81
article

Myostatin Levels in SMA Following Disease‐Modifying Treatments: A Multi‐Center Study

Adele D’Amico, Antonio Novelli, Giorgia Coratti, Fiorella Piemonte, Giacomo P. Comi, Eugenio Maria Mercuri, Anna Capasso, Maria Carmela Pera, Chiara Bravetti, Marika Pane, Marianna Villa, Stefania Paola Corti, Emanuela Abiusi, Silvia Baroni, Sara Petrillo, Francesco Danilo Tiziano, Michela Catteruccia, Chiara Arpaia, Concetta Palermo, Enrico Bertini, Stefania Fiori, Gianpaolo Cicala, Salvatore Falqui, Giulia Napoli
article en
1 citations

Abstract

This study demonstrates lower myostatin levels in SMA patients compared to controls. The association between myostatin levels, functional status, and SMA type suggests its possible role as a disease severity biomarker. The utility of myostatin as a biomarker for DMT response remains controversial; while we observed no significant increase in myostatin levels following treatment, we also did not observe the progressive reduction previously reported in untreated patients.

Annals of Clinical and Translational NeurologyVol. 12(7)
Università Cattolica del Sacro Cuore (IT), University of Parma (IT), University of Milan (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Centro Clinico Nemo (IT), Bambino Gesù Children's Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ferrari (Italy) (IT)
Ministero della Salute
Good health and well-being
Openalex Percentile: Top 28%
Muscle Physiology and Disorders
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.